Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis

NCT02464020 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02464020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02464020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2015
Completion date
December 1, 2018
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease, primary sclerosing cholangitis